122 related articles for article (PubMed ID: 33443960)
1. Age-period-cohort effects in utilization of diagnostic procedures leading to incidental colorectal cancer detection.
Salvatori A; Andreano A; Decarli A; Russo AG
Eur J Cancer Prev; 2022 Jan; 31(1):26-34. PubMed ID: 33443960
[TBL] [Abstract][Full Text] [Related]
2. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
3. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
[TBL] [Abstract][Full Text] [Related]
4. Long-term risk of colorectal cancer after screen-detected adenoma: Experiences from a Danish gFOBT-positive screening cohort.
Bjerrum A; Lindebjerg J; Andersen O; Fischer A; Lynge E
Int J Cancer; 2020 Aug; 147(4):940-947. PubMed ID: 31894860
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Screening Using Fecal Occult Blood Testing and Colonoscopy on the Risk of Colorectal Cancer: The Japan Public Health Center-based Prospective Study.
Tanaka K; Sobue T; Zha L; Kitamura T; Sawada N; Iwasaki M; Inoue M; Yamaji T; Tsugane S
J Epidemiol; 2023 Feb; 33(2):91-100. PubMed ID: 34053963
[TBL] [Abstract][Full Text] [Related]
6. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
Dollinger MM; Behl S; Fleig WE
Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
[TBL] [Abstract][Full Text] [Related]
7. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
[TBL] [Abstract][Full Text] [Related]
8. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
9. Systematic review with meta-analysis: faecal occult blood tests show lower colorectal cancer detection rates in the proximal colon in colonoscopy-verified diagnostic studies.
Hirai HW; Tsoi KK; Chan JY; Wong SH; Ching JY; Wong MC; Wu JC; Chan FK; Sung JJ; Ng SC
Aliment Pharmacol Ther; 2016 Apr; 43(7):755-64. PubMed ID: 26858128
[TBL] [Abstract][Full Text] [Related]
10. Colon Cancer Screening - Is It Time Yet?
Bhurgri H; Samiullah S
J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
[TBL] [Abstract][Full Text] [Related]
11. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
[TBL] [Abstract][Full Text] [Related]
12. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
Bjerrum A; Andersen O; Fischer A; Lindebjerg J; Lynge E
Int J Cancer; 2017 Aug; 141(3):503-511. PubMed ID: 28463410
[TBL] [Abstract][Full Text] [Related]
14. The fecal occult blood test as a tool for improved outpatient qualification for colonoscopy. A single-center experience and 10-year follow-up survey.
Banaszkiewicz Z; Budzyński J; Tojek K; Jarmocik P; Frasz J; Mrozowski M; Świtoński M; Jawień A
Adv Med Sci; 2017 Mar; 62(1):171-176. PubMed ID: 28282604
[TBL] [Abstract][Full Text] [Related]
15. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.
Gingold-Belfer R; Leibovitzh H; Boltin D; Issa N; Tsadok Perets T; Dickman R; Niv Y
United European Gastroenterol J; 2019 Apr; 7(3):424-448. PubMed ID: 31019712
[TBL] [Abstract][Full Text] [Related]
16. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA
Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.
Chen JG; Cai J; Wu HL; Xu H; Zhang YX; Chen C; Wang Q; Xu J; Yuan XL
World J Gastroenterol; 2012 Jun; 18(21):2682-8. PubMed ID: 22690078
[TBL] [Abstract][Full Text] [Related]
18. Options for screening for colorectal cancer.
Atkin W
Scand J Gastroenterol Suppl; 2003; (237):13-6. PubMed ID: 12797674
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Screening Modalities in Colorectal Cancer: A Network Meta-Analysis.
Zhang J; Cheng Z; Ma Y; He C; Lu Y; Zhao Y; Chang X; Zhang Y; Bai Y; Cheng N
Clin Colorectal Cancer; 2017 Dec; 16(4):252-263. PubMed ID: 28687458
[TBL] [Abstract][Full Text] [Related]
20. A population-based estimate of the extent of colorectal cancer screening in Ontario.
Rabeneck L; Paszat LF
Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]